Home › Abbvie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
 

Keywords :   


Abbvie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%

2015-02-02 19:46:47| Biotech - Topix.net

Abbvie reported solid Q4 earnings last week, despite one-time expenses for fees related to backing out of acquiring Shire Plc. Management did nothing to assuage investors that its HCV regimen was on pace to achieve its $2 billion 2015 revenue target.

Tags: sales fall projects shares

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
More »